C. Jennissen

Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients.

V. Ivaturi, Tao Liu, S. Pai, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A New Harmonized Approach to Estimate Busulfan Exposure Predicts Survival and Toxicity after Hematopoietic Cell Transplantation in Children and Young Adults : a Multicenter Retrospective Cohort Analysis

Yves, A. Egberts, M. Krajinovic, 2017 .

Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.

A. Egberts, M. Krajinovic, P. Veys, 2016, The Lancet. Haematology.

Reduced Toxicity (BuFlu) Conditioning Is Better Tolerated but Has Higher Second Transplant Rate Compared to Myeloablative Conditioning (BuCy) in Children with Inherited Metabolic Disorders.

P. Orchard, T. Lund, R. Shanley, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Busulfan dose recommendation in inherited metabolic disorders: Population pharmacokinetic analysis: Busulfan PK model in inherited metabolic disease.

P. Orchard, Takuto Takahashi, S. Illamola, 2021, Transplantation and cellular therapy.

Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation

J. Wagner, P. Jacobson, T. DeFor, 2009, Bone Marrow Transplantation.

A phase I dose finding study of intravenous voriconazole in pediatric patients undergoing hematopoietic cell transplantation

M. Kirstein, J. Fisher, Angela R. Smith, 2019, Bone Marrow Transplantation.